Clopamid, Pindolol - matokeo ya utafutaji kwa

viatris limited - clopidogrelbesilaat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotische middelen - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). het st-segment elevatie acuut myocardinfarct, in combinatie met asa in medisch behandelde patiënten in aanmerking komen voor trombolytische therapie. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. voor meer informatie refereer je naar sectie 5.

Ubelgiji - Kiholanzi - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

leponex 100 mg tabl.

viatris healthcare sa-nv - clozapine 100 mg - tablet - 100 mg - clozapine 100 mg - clozapine

Ubelgiji - Kiholanzi - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

leponex 25 mg tabl.

viatris healthcare sa-nv - clozapine 25 mg - tablet - 25 mg - clozapine 25 mg - clozapine

Uholanzi - Kiholanzi - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

clopidogrel xiromed 75 mg filmomhulde tabletten

clopidogrelbesilaat 112,1 mg/stuk samenstelling overeenkomend met ; clopidogrel 75 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; citroenzuur 1-water (e 330) ; crospovidon (e 1202) ; glyceroltriacetaat (e 1518) ; hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide rood (e 172) ; lactose 1-water ; macrogol 6000 ; mannitol (d-) (e 421) ; stearinezuur (e 570) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; citroenzuur 1-water (e 330) ; crospovidon (e 1202) ; glyceroltriacetaat (e 1518) ; hyprolose (e 463) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide rood (e 172) ; lactose 1-water ; macrogol 6000 ; mannitol (d-) (e 421) ; stearinezuur (e 570) ; talk (e 553 b) ; titaandioxide (e 171)